Impact of automated technology on the cervical cytologic smear: A comparison of cost

Acta Cytologica

Volumn 42, Issue 1, 1998, Pages 165-170

  Grohs, Dawn H ^a  

^a AccuMed International Inc   (United States)

Author keywords

Automation; Cost benefit analysis; Diagnosis, computer assisted; Mass screening

Indexed keywords

AUTOMATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER SCREENING; CONFERENCE PAPER; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MASS SCREENING; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

EID: 0031884453     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000331541     Document Type: Conference Paper

References (7)

1. DeMay R: Common Interpretive Errors in Pap Smears. CAP XXX: Liability and Quality Issues in Cervicovaginal Cytology. Chicago, ASCP Press, 1996
2. Frable W: Does Zero Error Standard Exist?: A Pathologist's Perspective. Presented at the CAP XXX Conference on Liability and Quality Issues in Cervicovaginal Cytology, Seattle/ June 6-9, 1996
3. Hutchinson M, Inhorn S, Papillo J: A perspective on modern quality control methods. Acta Cytol 1996;40:837-838
4. Kaminsky F, Burke R, Haberle K, Mullins D: An economic model for comparing alternative policies for cervical and cytologic smear screening. Acta Cytol 1995;39:232-238
5. Kaminsky F, Burke R, Haberle K, Mullins D: Statistical analysis of data in cervical cytology from the viewpoint of total quality management. Acta Cytol 1995;39:222-231
6. Kline T: Accomplishments of the Pap Smear: Presented at the CAP XXX Conference on Liability and Quality Issues in Cervicovaginal Cytology, Seattle, June 6-9, 1996
7. Kruger K, Snitkin E, Tabuteau H: Basic Report on Medical Products: Cytyc Corporation. Montgomery Securities 1996;27:50-52